Skip to content

Evaluation of cognitive function of Mild dementia with Neurofeedback

Evaluation of cognitive function of Mild dementia with Neurofeedback

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17014026
Enrollment
Unknown
Registered
2017-12-18
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild dementia

Interventions

experimental group:Neurofeedback
control group:False Neurofeedback

Sponsors

Fu Xing Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged arrange from 65 to 85 years old male and female, Junior high school education degree or above; 2. The patient's main complaint or the informant's report of memory impairment, slow onset, gradual progress,the symptom was last more than 6 months,18=MMSE=24,CDR>0.5; 3. Use conventional medicine for more than 2 months; 4. Can complete simple cognitive tasks, understand the guidance and can cooperate and adhere to the treatment course; 5. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. The dementia was caused by other etiology; 2. Acute stage of cerebral vessel disease; 3. Have a history of epilepsy and take antiepileptic drugs; 4. Having a history of mental illness, such as schizophrenia, severe anxiety and depression, etc.; 5. The condition that affect the test of cognitive function such as loss of language, severe hearing or visual impairment, lateral hemiplegia, etc.

Design outcomes

Primary

MeasureTime frame
ADAS-cog Score;

Secondary

MeasureTime frame
QEEG;Neuropsychological scale assessment;

Countries

China

Contacts

Public ContactXu Bin

Fu Xing Hospital, Capital Medical University

xubincj1992@aliyun.com+86 13691294377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026